CPhI 2017 THANK YOU30. 10. 2017
Dear business partners,
Safely back in the office after hectic CPhI 2017? It was good to see you all in Frankfurt am Main.
Saneca Pharma receives confirmation of multi-dosage cGMP approval for Russia16. 5. 2017
Contract development and manufacturing organisation (CDMO) Saneca Pharma has been granted a multiple dosage form approval for the manufacture and supply of solids, semi-solids and liquid finish dose products to Russia. The company achieved this cGMP certification following an inspection by the Federal State Institution ‘State Institute of Drugs and Good Practices’ of Russia.
Saneca to drive R&D Initiative following €1.5 million funding5. 12. 2016
Contract development and manufacturing organization (CDMO) Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (APIs) following a €1.5 million grant from the Slovak Ministry of Education, Science, Research and Sport.
Saneca Pharma secures Menarini Group contract9. 11. 2016
Slovakia-based contract development and manufacturing organisation (CDMO) Saneca Pharma has secured an agreement with Italian pharmaceutical company Menarini Group to deliver controlled release pellets for one of its products. As part of the five-year supply agreement, Saneca Pharma will be investing in its facility in Hlohovec, Slovakia, to increase the scale at which it can…
Saneca Pharma increases small scale API capabilities12. 9. 2016
CONTRACT development and manufacturing organization (CDMO) Saneca Pharma is strengthening its API capabilities to support client demand for smaller batch sizes and streamlined scale-up.
Did our portfolio meet your needs? Let´s discuss starting business with us.Contact us